DEPRESSIVE DISORDER, MAJOR
Clinical trials for DEPRESSIVE DISORDER, MAJOR explained in plain language.
Never miss a new study
Get alerted when new DEPRESSIVE DISORDER, MAJOR trials appear
Sign up with your email to follow new studies for DEPRESSIVE DISORDER, MAJOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Extended safety check for depression nasal spray shows promise
Disease control CompletedThis study followed 183 people with treatment-resistant depression to check the long-term safety of esketamine nasal spray when used alongside their regular antidepressant pills. Participants had already completed 32 weeks of treatment in a previous study and continued for up to …
Matched conditions: DEPRESSIVE DISORDER, MAJOR
Phase: PHASE4 • Sponsor: Janssen-Cilag Ltd. • Aim: Disease control
Last updated Apr 02, 2026 03:42 UTC
-
New hope for the joyless: experimental pill targets core symptom of depression
Disease control CompletedThis study tested whether adding a new daily pill called aticaprant to a person's current antidepressant could better treat major depression, specifically for people who experience a severe lack of pleasure (anhedonia). Over 500 adults who weren't getting enough benefit from thei…
Matched conditions: DEPRESSIVE DISORDER, MAJOR
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Brain exercises tested to lift mood and sharpen mind in older adults with depression
Disease control CompletedThis study tested whether computer-based brain training exercises could improve thinking skills and reduce depression in older adults who were already taking antidepressants. Researchers enrolled 38 older adults with mild to major depression, some with mild memory concerns, and r…
Matched conditions: DEPRESSIVE DISORDER, MAJOR
Phase: NA • Sponsor: UConn Health • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Brain light treatment tested for depression relief
Disease control CompletedThis study tested whether a non-invasive light therapy, delivered through a headset to the forehead, could help reduce symptoms of major depression. Fifty adults with depression were randomly assigned to receive either real light treatment at different settings or a fake (sham) t…
Matched conditions: DEPRESSIVE DISORDER, MAJOR
Phase: NA • Sponsor: NeuroThera DE • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for the joyless: pill aims to restore pleasure in Tough-to-Treat depression
Disease control CompletedThis study tested whether adding a new drug called aticaprant to a person's current antidepressant could help improve symptoms in adults with major depression who also experience a severe loss of pleasure (anhedonia) and haven't gotten enough relief from their current medication.…
Matched conditions: DEPRESSIVE DISORDER, MAJOR
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 02, 2026 15:21 UTC
-
Sleeping pill from a plant? cannabis oil tested for Depression-Related insomnia
Symptom relief CompletedThis small, completed pilot study explored whether a cannabis-infused oil could help improve sleep for people with major depression who also have chronic insomnia. Fourteen participants were randomly assigned to receive either a placebo or one of two oil formulas with different C…
Matched conditions: DEPRESSIVE DISORDER, MAJOR
Phase: PHASE2 • Sponsor: St. Joseph's Healthcare Hamilton • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC
-
Can sniffing scents lift your mood? study investigates
Symptom relief CompletedThis study tested whether daily smell training could improve mood and emotional perception in people with depressive symptoms. 150 participants, including healthy people and those diagnosed with depression, practiced smelling different odors daily for 3 months. Researchers measur…
Matched conditions: DEPRESSIVE DISORDER, MAJOR
Phase: NA • Sponsor: University Hospital, Tours • Aim: Symptom relief
Last updated Mar 23, 2026 15:15 UTC